echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Hengrui Pharmaceuticals " Grom bromine ammonium injection" was the first to be approved.

    Hengrui Pharmaceuticals " Grom bromine ammonium injection" was the first to be approved.

    • Last Update: 2020-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    September 28, Hengrui Pharmaceutical Class 3 generic drug Grombromide injection was officially approved by the State Drug Administration listed, becoming the first Glon ammonium bromide injection approved manufacturers.
    Grome ammonium bromide injection is an anticholinel energy drug, mainly for pre-anesthesia and intraoperative drugs, used to fight muscle pine antagonists, such as Nismin drugs, such as intestinal peristaltic enhancement, increased secretions, bronchial spasms and slow heart rate and other toxic side effects.
    Domestic preoperative use of anticholine drugs have atopyb, tobaalkali and pyridoline hydrochloride, atopyte as a clinical classic drug has been widely used so far, clinical applications, but the commonly used dose of atopenin can cause heart rate to increase faster, and the inhibitory effect of east palatealkali on respiratory gland secretion is slightly weaker than atopine, and atopin, east palladiumand saline ether can pass through the blood barrier.
    Compared with Athosin, ammonium Glon bromide inhibits salivary secretion for a strong and long-lasting effect, with low cardiovascular adverse reactions, and the drug lipid membrane has poor passability and is not easy to pass through the blood-brain barrier, thus affecting the central nervous system less.
    bromide is an ideal alternative to ato.
    ammonium bromide injection makes up for the shortage of existing clinical therapies and can better meet clinical needs.
    2017 global sales of about $180 million (source: IQVIA database), only Grombromin tablets (Tontine Pharmaceuticals) have been approved for market in China.
    first submitted an application for the listing of Glon ammonium bromide injections in May 2018 and was included in the priority review in September of the same year as an "innovative drug with significant therapeutic advantages".
    china also has Yuandong Bio, Jiabo Pharmaceuticals and Coastal Pharmaceuticals submitted applications for the drug to market.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.